Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2018, Article ID 4098140, 10 pages
Research Article

A Nonenzymatic and Automated Closed-Cycle Process for the Isolation of Mesenchymal Stromal Cells in Drug Delivery Applications

1CRC StaMeTec, Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy
2I.R.C.C.S Galeazzi Orthopedic Institute, Milan, Italy
3Maxillofacial and Dental Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Via Commenda 10, 20122 Milan, Italy
4Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy
5University Research Center “Integrated Models for Prevention and Protection in Environmental and Occupational Health” (MISTRAL), Brescia, Italy
6Cellular Neurobiology Laboratory, Department of Cerebrovascular Diseases, Fondazione IRCCS Neurological Institute C. Besta, Milan, Italy
7Image Institute, Milan, Italy
8Lipogems International Spa, Milan, Italy
9Hydra srl, Mirandola, Modena, Italy

Correspondence should be addressed to Augusto Pessina; ti.iminu@anissep.otsugua

Received 12 October 2017; Accepted 25 December 2017; Published 20 February 2018

Academic Editor: Massimo Petruzzi

Copyright © 2018 Valentina Coccè et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The adipose tissue is a good source of mesenchymal stromal cells that requires minimally invasive isolation procedures. To ensure reproducibility, efficacy, and safety for clinical uses, these procedures have to be in compliant with good manufacturing practices. Techniques for harvesting and processing human adipose tissue have rapidly evolved in the last years, and Lipogems® represents an innovative approach to obtain microfragmented adipose tissue in a short time, without expansion and/or enzymatic treatment. The aim of this study was to assess the presence of mesenchymal stromal cells in the drain bag of the device by using a prototype Lipogems processor to wash the lipoaspirate in standardized condition. We found that, besides oil and blood residues, the drain bag contained single isolated cells easy to expand and with the typical characteristics of mesenchymal stromal cells that can be loaded with paclitaxel to use for drug-delivery application. Our findings suggest the possibility to replace the drain bag with a “cell culture chamber” obtaining a new integrated device that, without enzymatic treatment, can isolate and expand mesenchymal stromal cells in one step with high good manufacturing practices compliance. This system could be used to obtain mesenchymal stromal cells for regenerative purposes and for drug delivery.